Die Suchmaschine für Unternehmensdaten in Europa

UK-Förderung (7.073.464 £): LSI DTCs 2007 - Graduiertenakademie für Tissue Engineering und Regenerative Medizin Ukri 01.10.2008 Forschung und Innovation im Vereinigten Königreich, Großbritannien

Auf einen Blick

Text

LSI DTCs 2007 - Graduiertenakademie für Tissue Engineering und Regenerative Medizin

Zusammenfassung Definition: A rapidly developing area at the interfaces of engineering/physical sciences, life sciences and medicine. Includes:- cell therapies (including stem cells), three dimensional cell/ matrix constructs, bioactive scaffolds, regenerative devices, in vitro tissue models for drug discovery and pre-clinical research.Social and economic needs include:Increased longevity of the ageing population with expectations of an active lifestyle and government requirements for a longer working life.Need to reduce healthcare costs, shorten hospital stays and achieve more rapid rehabilitationAn emergent disruptive industrial sector at the interface between pharmaceutical and medical devicesRequirement for relevant laboratory biological systems for screening and selection of drugs at theearly development stage, coupled with Reduction, Refinement, Replacement of in vivo testing. Translational barriers and industry needs: The tissue engineering/ regenerative medicine industry needs an increase in the number of trained multidisciplinary personnel to translate basic research, deliver new product developments, enhance manufacturing and processing capacity, to develop preclinical test methodologies and to develop standards and work within a dynamic regulatory environment. Evidence from N8 industry workshop on regenerative medicine.Academic needs: A rapidly emerging internationally competitive interdisciplinary area requiring new blood ---------------------
Kategorie Training Grant
Referenz EP/F500513/1
Status Closed
Laufzeit von 01.10.2008
Laufzeit bis 30.09.2018
Fördersumme 7.073.464,00 £
Quelle https://gtr.ukri.org/projects?ref=EP%2FF500513%2F1

Beteiligte Organisationen

University of Leeds
Intercytex Ltd
Innovate UK
Axordia Ltd
Yorkshire Forward
Xiros Plc
Gluco Ltd (Leeds Innovation Centre)
Tissue Science Laboratories (Uk) Ltd
DePuy Synthes (International)
National Blood Service
BITECIC Ltd
White Rose University Consortium
CellTran Ltd
Smith and Nephew Medical Ltd

Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: University of Leeds, LS2 9JT Leeds, Großbritannien.